Publicacións nas que colabora con M. Barreiro de Acosta (7)

2021

  1. Effectiveness of ustekinumab in fistulising perianal Crohn′s disease refractory or intolerant to anti-TNF

    Journal of Crohn's and Colitis, Vol. 15, Núm. Supplement_1, pp. S419-S420

2017

  1. P186 Association between anti-TNF serum levels and mucosal healing in inflammatory bowel disease

    Journal of Crohn's and Colitis, Vol. 11, Núm. suppl_1, pp. S171-S171

  2. P423 Early improvement in quality of life in patients with luminal Crohn's disease treated with adalimumab. Data from RAPIDA trial

    Journal of Crohn's and Colitis, Vol. 11, Núm. suppl_1, pp. S291-S292

2016

  1. P521. Anti-TNF serum level and clinical, radiological or endoscopical response in luminal and perianal Crohn’s disease: results of the OPTIMIZA study

    Journal of Crohn's and Colitis, Vol. 10, Núm. suppl 1, pp. S364.1-S364

2015

  1. P526. Impact of postinduction infliximab trough level and disease activity on primary response in Crohn's Disease

    Journal of Crohn's and Colitis, Vol. 9, Núm. suppl 1, pp. S342-S343

2008

  1. P229 INFLUENCE OF RURAL/URBAN ENVIRONMENT IN THE SEVERITY OF INFLAMMATORY BOWEL DISEASE

    Journal of Crohn's and Colitis Supplements, Vol. 2, Núm. 1, pp. 72

2004

  1. Tratamiento de la diarrea

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 9, Núm. 3, pp. 193-199